TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway

Published:2019-10-21 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Tang Genxiong¹,Tang Qi²,Jia Lizhou²,Chen Yuan³,Lin Liangyuan¹,Kuai Xingwang⁴,Gong Aixiu¹,Feng Zhengqing⁵

Affiliation:

1. Department of Stomatology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China

2. National Health Commission Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China

3. Department of Otolaryngology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, P.R. China

4. Department of Basic Medicine, Jiangsu College of Nursing, Huai'an, Jiangsu 223001, P.R. China

5. Department of Pathology, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back;Frontiers in Immunology;2024-08-15

2. ImmunoPET imaging of Trop2 in patients with solid tumours;EMBO Molecular Medicine;2024-04-02

3. Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements;Frontiers in Oncology;2023-10-24

4. Selenium modulates AR/IGF-1R/EGFR and TROP2 signaling pathways and improves anticancer efficacy in murine mammary carcinoma 4T1;The Journal of Nutritional Biochemistry;2023-10

5. Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan;npj Breast Cancer;2023-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3